We use cookies to improve site performance and enhance your user experience. If you'd like to disable cookies on this device, please see our cookie management page.
If you close this message or continue to use this site, you consent to our use of cookies on this devise in accordance with our cookie policy, unless you disable them.

Close

registration required

or
for more website access

This content can only be viewed by subscribers and registered users of Investors Chronicle.

Subscribe or register free today

Shareholder revolt at Meldex

Shareholders in specialty pharma group Meldex have called for assurances that the company will moderate its issuance of new equity to pay for acquisitions, and expressed concern about the depth of due diligence being performed on vendor companies. Their concerns are expected to take centre stage at the company's annual meeting today, ahead of which one of the company's non-executives has resigned.

registration required

visible-status-Subscription-Only story-url-Meldex_news_230508.xml

By Richard Hemming,
26 June 2008

Print this article

Related Companies

Register today and get...

Register today and get...
Please note terms & conditions apply